Overexpression of RAD50 is the Marker of Poor Prognosis and Drug Resistance in Breast Cancer Patients.
Sign Up to like & getrecommendations! Published in 2020 at "Current cancer drug targets"
DOI: 10.2174/1568009620666201009125507
Abstract: BACKGROUND The prevalence of breast cancer is increasing at an alarming rate and thus demands exploration of most relevant diagnostic biomarkers. RAD50 is a cancer susceptibility gene which encodes a DNA damage repairing protein. Its… read more here.
Keywords: cancer; rad50 expression; rad50; breast cancer ... See more keywords